We are monitoring the impact of COVID-19 on Latin America Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Get in touch with us for detailed analysis Know More
Share on

Latin America Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Research Report - By Treatment, Medication, Psychotherapy, Education or Training & Country (Mexico, Brazil, Argentina, Chile & Rest of Latin America) - Industry Size, Growth, Trends & Forecasts (2022 to 2027)

Published: January, 2022
ID: 268
Pages: 145

Latin America ADHD Therapeutics Market Size (2022 to 2027)

ADHD Therapeutics Market in Latin America is expected to reach USD 1.53 billion by 2027 from USD 0.91 billion in 2022, growing at a CAGR of 10.90% from 2022 to 2027.

Attention deficit hyperactivity disorder (ADHD) is one of the most common neurological/psychiatric disorders among children and adolescents. ADHD is commonly observed in children (<12 years of age) compared to adolescents. ADHD is also described as hyperkinetic disorder/ attention deficit or neuropsychiatric disorder. The exact cause for ADHD is unclear but expected to result from genetic factors and environmental influences. ADHD results in improper functioning of the nervous system that leads to attention deficit and hyperactivity/impulsiveness conditions. Specific symptoms that characterize ADHD include easy distraction & striving to maintain focus on one task, unable to remember things, impatience, and being continuously in motion, among others. The symptoms of attention deficit hyperactivity disorder (ADHD) are controlled by different modalities such as medication (stimulants-amphetamines; non-stimulants-atomoxetine), psychotherapy (behavior therapy, cognitive behavioral therapy), and education/training (parent management training, family training).

The growing number of learning disability patients, the rising number of treatment solutions, and government initiatives towards adopting innovative neurological disorders therapeutics are some of the major factors driving the growth of the attention-deficit hyperactivity disorder (ADHD) therapeutics market in Latin America.

However, the low adoption of attention deficit hyperactivity disorder therapeutics and the high cost to maintain longer medications for the treatment of ADHD are some of the factors restraining the growth of the ADHD Therapeutics Market in Latin America.

This research report on the Latin America ADHD Therapeutics Market is segmented and sub-segmented into the following categories:

By Medication:

  • Stimulants
  • Non-Stimulants

By Psychotherapy:

  • Behaviour Therapy
  • Cognitive Behavioural Therapy
  • Interpersonal Psychotherapy
  • Family Therapy

By Education or Training:

  • Parent Management Training
  • Social Skills Training
  • School-Based Interventions

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Latin American is estimated to do well in the global market during the forecast period. Brazil, followed by Mexico, is expected to occupy the majority of the share in the Latin American market throughout the forecast period.

KEY MARKET PLAYERS:

Companies playing a vital role in the Latin America ADHD Therapeutics Market are Shire plc (Ireland), Neos Therapeutics, Inc. (U.S.), Eli Lilly and Company (U.S.), Pfizer Inc. (U.S.), Alcobra Ltd. (Israel), Supernus Pharmaceuticals, Inc. (U.S.), Noven Pharmaceuticals, Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson (U.S.) and Curemark, LLC. (U.S.).

  1. Introduction

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

  1. Research Methodology

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

  1. Overview

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

  1. Market Segmentation

                5.1 Introduction                                               

                5.2 Treatment By Medication                                    

                                5.2.1 Introduction                           

                                5.2.2 Stimulants                               

                                                5.2.2.1 Introduction       

                                                5.2.2.2 Amphetamines 

                                                5.2.2.3 Methylphenidate             

                                                5.2.2.4 Dextroamphetamine      

                                                5.2.2.5 Dexmethylphenidate     

                                5.2.3 Non-Stimulants                     

                                                5.2.3.1 Introduction       

                                                5.2.3.2 Atomoxetine      

                                                5.2.3.3 Bupropion           

                                                5.2.3.4 Guanfacine         

                5.3 Treatment By Psychotherapy                                             

                                5.3.1 Introduction                           

                                5.3.2 Behavior Therapy                 

                                5.3.3 Cognitive Behavioral Therapy                         

                                5.3.4 Interpersonal Psychotherapy                         

                                5.3.5 Family Therapy                      

                5.4 Treatment By Education or Training                                 

                                5.3.1 Introduction                           

                                5.3.2 Parent Management Training                         

                                5.3.3 Social Skills Training                             

                                5.3.4 School-Based Interventions                            

  1. Geographical Analysis

                                6.4.1 Introduction                           

                                6.4.2 Brazil                          

                                6.4.3 Argentina                

                                6.4.4 Mexico                     

  1. Strategic Analysis

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

  1. Market Leaders' Analysis

                8.1 Shire plc (Ireland)                                    

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Neos Therapeutics, Inc. (U.S.)                                            

                8.3 Eli Lilly and Company (U.S.)                                  

                8.4 Pfizer Inc. (U.S.)                                       

                8.5 Alcobra Ltd. (Israel)                                 

                8.6 Supernus Pharmaceuticals, Inc. (U.S.)                                            

                8.7 Noven Pharmaceuticals, Inc. (U.S.)                                  

                8.8 Novartis AG (Switzerland)                                    

                8.9 Johnson & Johnson (U.S.)                                    

                8.10 Curemark, LLC., (U.S.)                                         

  1. Competitive Landscape

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

  1. Expert Opinions

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

    Appendix                                                          

a) List of Tables

b) List of Figures

  1. Latin America Attention-Deficit Hyperactivity Disorder Therapeutics Market By Region, From 2022 - 2027 (USD Billion)
  2. Latin America Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2022 - 2027 (USD Billion)
  3. Latin America Stimulants Market By Region, From 2022 - 2027 (USD Billion)
  4. Latin America Non-Stimulants Market By Region, From 2022 - 2027 (USD Billion)
  5. Latin America Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2022 - 2027 (USD Billion)
  6. Latin America Behavior Therapy ADHD Therapeutics Market By Region, From 2022 - 2027 (USD Billion)
  7. Latin America Cognitive Behavioral Therapy ADHD Therapeutics Market By Region, From 2022 - 2027 (USD Billion)
  8. Latin America Interpersonal Psychotherapy ADHD Therapeutics Market By Region, From 2022 - 2027 (USD Billion)
  9. Latin America Family Therapy ADHD Therapeutics Market By Region, From 2022 - 2027 (USD Billion)
  10. Latin America Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2022 - 2027 (USD Billion)
  11. Latin America Parent Management Training ADHD Therapeutics Market By Region, From 2022 - 2027 (USD Billion)
  12. Latin America Social Skills Training ADHD Therapeutics Market By Region, From 2022 - 2027 (USD Billion)
  13. Latin America School-based Interventions ADHD Therapeutics Market By Region, From 2022 - 2027 (USD Billion)
  14. Brazil Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2022 - 2027 (USD Billion)
  15. Brazil Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2022 - 2027 (USD Billion)
  16. Brazil Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2022 - 2027 (USD Billion)
  17. Argentina Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2022 - 2027 (USD Billion)
  18. Argentina Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2022 - 2027 (USD Billion)
  19. Argentina Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2022 - 2027 (USD Billion)
  20. Mexico Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2022 - 2027 (USD Billion)
  21. Mexico Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2022 - 2027 (USD Billion)
  22. Mexico Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2022 - 2027 (USD Billion)
  23. Latin America Stimulants ADHD Therapeutics Market By Type, From 2022 - 2027 (USD Billion)
  24. Latin America Amphetamines Market By Region, From 2022 - 2027 (USD Billion)
  25. Latin America Methylphenidate Market By Region, From 2022 - 2027 (USD Billion)
  26. Latin America Dextroamphetamine Market By Region, From 2022 - 2027 (USD Billion)
  27. Latin America Dexmethylphenidate Market By Region, From 2022 - 2027 (USD Billion)
  28. Brazil Stimulants ADHD Therapeutics Market By Type, From 2022 - 2027 (USD Billion)
  29. Argentina Stimulants ADHD Therapeutics Market By Type, From 2022 - 2027 (USD Billion)
  30. Mexico Stimulants ADHD Therapeutics Market By Type, From 2022 - 2027 (USD Billion)
  31. Latin America Non-Stimulants ADHD Therapeutics Market By Type, From 2022 - 2027 (USD Billion)
  32. Latin America Atomoxetine Market By Region, From 2022 - 2027 (USD Billion)
  33. Latin America Bupropion Market By Region, From 2022 - 2027 (USD Billion)
  34. Latin America Guanfacine Market By Region, From 2022 - 2027 (USD Billion)
  35. Brazil Non-Stimulants ADHD Therapeutics Market By Type, From 2022 - 2027 (USD Billion)
  36. Argentina Non-Stimulants ADHD Therapeutics Market By Type, From 2022 - 2027 (USD Billion)
  37. Mexico Non-Stimulants ADHD Therapeutics Market By Type, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample